nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfinpyrazone—ABCC3—hematologic cancer	0.26	0.832	CbGaD
Sulfinpyrazone—ABCB1—hematologic cancer	0.0526	0.168	CbGaD
Sulfinpyrazone—ABCC6—Daunorubicin—hematologic cancer	0.0503	0.0834	CbGbCtD
Sulfinpyrazone—ABCC6—Teniposide—hematologic cancer	0.0437	0.0725	CbGbCtD
Sulfinpyrazone—ABCC4—Tioguanine—hematologic cancer	0.0344	0.0571	CbGbCtD
Sulfinpyrazone—ABCC5—Mercaptopurine—hematologic cancer	0.0298	0.0494	CbGbCtD
Sulfinpyrazone—ABCC6—Vinblastine—hematologic cancer	0.0214	0.0355	CbGbCtD
Sulfinpyrazone—ABCC1—Idarubicin—hematologic cancer	0.021	0.0348	CbGbCtD
Sulfinpyrazone—ABCC6—Cisplatin—hematologic cancer	0.0196	0.0325	CbGbCtD
Sulfinpyrazone—ABCC6—Etoposide—hematologic cancer	0.0193	0.032	CbGbCtD
Sulfinpyrazone—ABCC5—Cisplatin—hematologic cancer	0.015	0.0249	CbGbCtD
Sulfinpyrazone—ABCC1—Daunorubicin—hematologic cancer	0.0148	0.0246	CbGbCtD
Sulfinpyrazone—ABCC4—Mercaptopurine—hematologic cancer	0.0143	0.0237	CbGbCtD
Sulfinpyrazone—ABCC6—Doxorubicin—hematologic cancer	0.0132	0.0218	CbGbCtD
Sulfinpyrazone—ABCC2—Daunorubicin—hematologic cancer	0.011	0.0182	CbGbCtD
Sulfinpyrazone—ABCC3—Vincristine—hematologic cancer	0.0101	0.0168	CbGbCtD
Sulfinpyrazone—CYP2B6—Thiotepa—hematologic cancer	0.00987	0.0164	CbGbCtD
Sulfinpyrazone—ABCC3—Cisplatin—hematologic cancer	0.00943	0.0156	CbGbCtD
Sulfinpyrazone—ABCC3—Etoposide—hematologic cancer	0.00926	0.0154	CbGbCtD
Sulfinpyrazone—ABCC1—Mitoxantrone—hematologic cancer	0.00902	0.015	CbGbCtD
Sulfinpyrazone—ABCC1—Epirubicin—hematologic cancer	0.0073	0.0121	CbGbCtD
Sulfinpyrazone—ABCC1—Irinotecan—hematologic cancer	0.0071	0.0118	CbGbCtD
Sulfinpyrazone—ABCC3—Doxorubicin—hematologic cancer	0.00632	0.0105	CbGbCtD
Sulfinpyrazone—ABCC1—Vinblastine—hematologic cancer	0.00631	0.0105	CbGbCtD
Sulfinpyrazone—CYP2C9—Bexarotene—hematologic cancer	0.00629	0.0104	CbGbCtD
Sulfinpyrazone—ABCC1—Vincristine—hematologic cancer	0.00621	0.0103	CbGbCtD
Sulfinpyrazone—ABCC3—Methotrexate—hematologic cancer	0.00612	0.0101	CbGbCtD
Sulfinpyrazone—ABCB1—Lenalidomide—hematologic cancer	0.00611	0.0101	CbGbCtD
Sulfinpyrazone—ABCC1—Etoposide—hematologic cancer	0.00569	0.00943	CbGbCtD
Sulfinpyrazone—CYP2B6—Ifosfamide—hematologic cancer	0.0056	0.00929	CbGbCtD
Sulfinpyrazone—CYP2C8—Bortezomib—hematologic cancer	0.00553	0.00917	CbGbCtD
Sulfinpyrazone—ABCC2—Irinotecan—hematologic cancer	0.00526	0.00872	CbGbCtD
Sulfinpyrazone—CYP2C9—Idarubicin—hematologic cancer	0.00522	0.00865	CbGbCtD
Sulfinpyrazone—CYP2B6—Nilotinib—hematologic cancer	0.00486	0.00806	CbGbCtD
Sulfinpyrazone—ABCC4—Methotrexate—hematologic cancer	0.00468	0.00775	CbGbCtD
Sulfinpyrazone—ABCC2—Vinblastine—hematologic cancer	0.00467	0.00775	CbGbCtD
Sulfinpyrazone—ABCC2—Vincristine—hematologic cancer	0.00459	0.00762	CbGbCtD
Sulfinpyrazone—ABCC2—Cisplatin—hematologic cancer	0.00428	0.0071	CbGbCtD
Sulfinpyrazone—CYP2C8—Ifosfamide—hematologic cancer	0.00424	0.00703	CbGbCtD
Sulfinpyrazone—ABCC2—Etoposide—hematologic cancer	0.00421	0.00698	CbGbCtD
Sulfinpyrazone—ABCC1—Doxorubicin—hematologic cancer	0.00388	0.00643	CbGbCtD
Sulfinpyrazone—CYP2C9—Bortezomib—hematologic cancer	0.00386	0.0064	CbGbCtD
Sulfinpyrazone—ABCC1—Methotrexate—hematologic cancer	0.00376	0.00623	CbGbCtD
Sulfinpyrazone—CYP2C8—Nilotinib—hematologic cancer	0.00368	0.00611	CbGbCtD
Sulfinpyrazone—CYP3A4—Bexarotene—hematologic cancer	0.00366	0.00607	CbGbCtD
Sulfinpyrazone—ABCB1—Daunorubicin—hematologic cancer	0.00358	0.00594	CbGbCtD
Sulfinpyrazone—ABCB1—Alitretinoin—hematologic cancer	0.00351	0.00582	CbGbCtD
Sulfinpyrazone—ABCC2—Dexamethasone—hematologic cancer	0.00346	0.00574	CbGbCtD
Sulfinpyrazone—CYP3A4—Lomustine—hematologic cancer	0.0034	0.00564	CbGbCtD
Sulfinpyrazone—CYP3A4—Busulfan—hematologic cancer	0.0034	0.00564	CbGbCtD
Sulfinpyrazone—CYP2C9—Thalidomide—hematologic cancer	0.00336	0.00557	CbGbCtD
Sulfinpyrazone—CYP2B6—Irinotecan—hematologic cancer	0.00334	0.00554	CbGbCtD
Sulfinpyrazone—CYP2C9—Teniposide—hematologic cancer	0.00321	0.00532	CbGbCtD
Sulfinpyrazone—CYP3A4—Thiotepa—hematologic cancer	0.00303	0.00503	CbGbCtD
Sulfinpyrazone—CYP2C9—Ifosfamide—hematologic cancer	0.00296	0.00491	CbGbCtD
Sulfinpyrazone—ABCC2—Doxorubicin—hematologic cancer	0.00287	0.00476	CbGbCtD
Sulfinpyrazone—CYP2C9—Imatinib—hematologic cancer	0.00283	0.00469	CbGbCtD
Sulfinpyrazone—ABCC2—Methotrexate—hematologic cancer	0.00278	0.00461	CbGbCtD
Sulfinpyrazone—ABCB1—Imatinib—hematologic cancer	0.00274	0.00455	CbGbCtD
Sulfinpyrazone—CYP2B6—Cisplatin—hematologic cancer	0.00272	0.00452	CbGbCtD
Sulfinpyrazone—CYP2C9—Nilotinib—hematologic cancer	0.00257	0.00426	CbGbCtD
Sulfinpyrazone—ABCB1—Nilotinib—hematologic cancer	0.00249	0.00413	CbGbCtD
Sulfinpyrazone—ABCB1—Vinorelbine—hematologic cancer	0.00247	0.0041	CbGbCtD
Sulfinpyrazone—CYP3A4—Methoxsalen—hematologic cancer	0.00236	0.00391	CbGbCtD
Sulfinpyrazone—CYP3A4—Bortezomib—hematologic cancer	0.00224	0.00372	CbGbCtD
Sulfinpyrazone—ABCB1—Dasatinib—hematologic cancer	0.0022	0.00365	CbGbCtD
Sulfinpyrazone—CYP2B6—Dexamethasone—hematologic cancer	0.0022	0.00365	CbGbCtD
Sulfinpyrazone—ABCB1—Mitoxantrone—hematologic cancer	0.00218	0.00361	CbGbCtD
Sulfinpyrazone—CYP3A4—Daunorubicin—hematologic cancer	0.00215	0.00356	CbGbCtD
Sulfinpyrazone—CYP2C8—Etoposide—hematologic cancer	0.00203	0.00336	CbGbCtD
Sulfinpyrazone—ABCB1—Betamethasone—hematologic cancer	0.00194	0.00322	CbGbCtD
Sulfinpyrazone—ABCB1—Gemcitabine—hematologic cancer	0.00192	0.00319	CbGbCtD
Sulfinpyrazone—ABCB1—Prednisolone—hematologic cancer	0.00191	0.00317	CbGbCtD
Sulfinpyrazone—CYP3A4—Cytarabine—hematologic cancer	0.00189	0.00314	CbGbCtD
Sulfinpyrazone—CYP3A4—Teniposide—hematologic cancer	0.00186	0.00309	CbGbCtD
Sulfinpyrazone—CYP2B6—Doxorubicin—hematologic cancer	0.00183	0.00303	CbGbCtD
Sulfinpyrazone—ABCB1—Prednisone—hematologic cancer	0.00181	0.003	CbGbCtD
Sulfinpyrazone—CYP3A4—Ifosfamide—hematologic cancer	0.00172	0.00285	CbGbCtD
Sulfinpyrazone—ABCB1—Irinotecan—hematologic cancer	0.00171	0.00284	CbGbCtD
Sulfinpyrazone—CYP2C8—Dexamethasone—hematologic cancer	0.00167	0.00276	CbGbCtD
Sulfinpyrazone—ABCC6—hematopoietic system—hematologic cancer	0.00165	0.0747	CbGeAlD
Sulfinpyrazone—CYP3A4—Imatinib—hematologic cancer	0.00164	0.00273	CbGbCtD
Sulfinpyrazone—FABP2—lymph node—hematologic cancer	0.00157	0.0711	CbGeAlD
Sulfinpyrazone—CYP3A4—Ruxolitinib—hematologic cancer	0.00155	0.00257	CbGbCtD
Sulfinpyrazone—ABCB1—Vinblastine—hematologic cancer	0.00152	0.00253	CbGbCtD
Sulfinpyrazone—ABCB1—Vincristine—hematologic cancer	0.0015	0.00248	CbGbCtD
Sulfinpyrazone—CYP3A4—Nilotinib—hematologic cancer	0.00149	0.00248	CbGbCtD
Sulfinpyrazone—CYP3A4—Vinorelbine—hematologic cancer	0.00148	0.00246	CbGbCtD
Sulfinpyrazone—CYP2C9—Cisplatin—hematologic cancer	0.00144	0.00239	CbGbCtD
Sulfinpyrazone—ABCB1—Cisplatin—hematologic cancer	0.0014	0.00232	CbGbCtD
Sulfinpyrazone—ABCB1—Etoposide—hematologic cancer	0.00137	0.00228	CbGbCtD
Sulfinpyrazone—ABCC6—Podofilox—Teniposide—hematologic cancer	0.00137	0.627	CbGdCrCtD
Sulfinpyrazone—CYP3A4—Triamcinolone—hematologic cancer	0.00135	0.00225	CbGbCtD
Sulfinpyrazone—CYP3A4—Dasatinib—hematologic cancer	0.00132	0.00219	CbGbCtD
Sulfinpyrazone—CYP3A4—Mitoxantrone—hematologic cancer	0.0013	0.00216	CbGbCtD
Sulfinpyrazone—CYP2C9—Dexamethasone—hematologic cancer	0.00116	0.00193	CbGbCtD
Sulfinpyrazone—CYP3A4—Betamethasone—hematologic cancer	0.00116	0.00193	CbGbCtD
Sulfinpyrazone—CYP3A4—Prednisolone—hematologic cancer	0.00115	0.0019	CbGbCtD
Sulfinpyrazone—ABCB1—Dexamethasone—hematologic cancer	0.00113	0.00187	CbGbCtD
Sulfinpyrazone—ABCC6—blood—hematologic cancer	0.0011	0.0495	CbGeAlD
Sulfinpyrazone—CYP3A4—Prednisone—hematologic cancer	0.00108	0.0018	CbGbCtD
Sulfinpyrazone—CYP3A4—Irinotecan—hematologic cancer	0.00103	0.0017	CbGbCtD
Sulfinpyrazone—ABCC6—lung—hematologic cancer	0.000961	0.0434	CbGeAlD
Sulfinpyrazone—ABCC3—hematopoietic system—hematologic cancer	0.000944	0.0426	CbGeAlD
Sulfinpyrazone—ABCB1—Doxorubicin—hematologic cancer	0.000936	0.00155	CbGbCtD
Sulfinpyrazone—CYP3A4—Vinblastine—hematologic cancer	0.000913	0.00151	CbGbCtD
Sulfinpyrazone—ABCB1—Methotrexate—hematologic cancer	0.000907	0.0015	CbGbCtD
Sulfinpyrazone—CYP3A4—Vincristine—hematologic cancer	0.000897	0.00149	CbGbCtD
Sulfinpyrazone—CYP3A4—Etoposide—hematologic cancer	0.000822	0.00136	CbGbCtD
Sulfinpyrazone—ABCC6—Podofilox—Etoposide—hematologic cancer	0.000815	0.373	CbGdCrCtD
Sulfinpyrazone—ABCC4—hematopoietic system—hematologic cancer	0.000779	0.0352	CbGeAlD
Sulfinpyrazone—ABCC5—bone marrow—hematologic cancer	0.000721	0.0325	CbGeAlD
Sulfinpyrazone—CYP3A4—Dexamethasone—hematologic cancer	0.000676	0.00112	CbGbCtD
Sulfinpyrazone—ABCC5—lung—hematologic cancer	0.000653	0.0295	CbGeAlD
Sulfinpyrazone—ABCC3—blood—hematologic cancer	0.000626	0.0282	CbGeAlD
Sulfinpyrazone—ABCC5—testis—hematologic cancer	0.000616	0.0278	CbGeAlD
Sulfinpyrazone—CYP2C8—hematopoietic system—hematologic cancer	0.000566	0.0255	CbGeAlD
Sulfinpyrazone—CYP3A4—Doxorubicin—hematologic cancer	0.000561	0.00093	CbGbCtD
Sulfinpyrazone—ABCC3—lung—hematologic cancer	0.000548	0.0247	CbGeAlD
Sulfinpyrazone—ABCC3—testis—hematologic cancer	0.000517	0.0234	CbGeAlD
Sulfinpyrazone—ABCC4—blood—hematologic cancer	0.000516	0.0233	CbGeAlD
Sulfinpyrazone—CYP2B6—hematopoietic system—hematologic cancer	0.000508	0.0229	CbGeAlD
Sulfinpyrazone—CYP2C9—hematopoietic system—hematologic cancer	0.000503	0.0227	CbGeAlD
Sulfinpyrazone—ABCC2—blood—hematologic cancer	0.0005	0.0226	CbGeAlD
Sulfinpyrazone—ABCC4—bone marrow—hematologic cancer	0.0005	0.0225	CbGeAlD
Sulfinpyrazone—ABCC4—lung—hematologic cancer	0.000453	0.0204	CbGeAlD
Sulfinpyrazone—ABCC5—lymph node—hematologic cancer	0.000447	0.0202	CbGeAlD
Sulfinpyrazone—ABCC1—blood—hematologic cancer	0.00044	0.0199	CbGeAlD
Sulfinpyrazone—ABCC4—testis—hematologic cancer	0.000427	0.0193	CbGeAlD
Sulfinpyrazone—ABCC2—testis—hematologic cancer	0.000413	0.0187	CbGeAlD
Sulfinpyrazone—ABCC1—lung—hematologic cancer	0.000386	0.0174	CbGeAlD
Sulfinpyrazone—CYP2B6—gonad—hematologic cancer	0.000386	0.0174	CbGeAlD
Sulfinpyrazone—CYP3A4—hematopoietic system—hematologic cancer	0.000383	0.0173	CbGeAlD
Sulfinpyrazone—ABCC3—lymph node—hematologic cancer	0.000375	0.0169	CbGeAlD
Sulfinpyrazone—CYP2C8—blood—hematologic cancer	0.000375	0.0169	CbGeAlD
Sulfinpyrazone—ABCC1—testis—hematologic cancer	0.000364	0.0164	CbGeAlD
Sulfinpyrazone—CYP2B6—blood—hematologic cancer	0.000336	0.0152	CbGeAlD
Sulfinpyrazone—CYP2C9—blood—hematologic cancer	0.000333	0.015	CbGeAlD
Sulfinpyrazone—CYP2C8—testis—hematologic cancer	0.00031	0.014	CbGeAlD
Sulfinpyrazone—ABCC4—lymph node—hematologic cancer	0.00031	0.014	CbGeAlD
Sulfinpyrazone—ABCC2—lymph node—hematologic cancer	0.0003	0.0135	CbGeAlD
Sulfinpyrazone—CYP2B6—lung—hematologic cancer	0.000295	0.0133	CbGeAlD
Sulfinpyrazone—CYP2B6—testis—hematologic cancer	0.000278	0.0126	CbGeAlD
Sulfinpyrazone—ABCB1—hematopoietic system—hematologic cancer	0.000271	0.0122	CbGeAlD
Sulfinpyrazone—ABCC1—lymph node—hematologic cancer	0.000264	0.0119	CbGeAlD
Sulfinpyrazone—CYP3A4—blood—hematologic cancer	0.000254	0.0115	CbGeAlD
Sulfinpyrazone—Clotrimazole—ABCC3—hematologic cancer	0.000219	0.832	CrCbGaD
Sulfinpyrazone—ABCB1—gonad—hematologic cancer	0.000206	0.00931	CbGeAlD
Sulfinpyrazone—ABCB1—blood—hematologic cancer	0.00018	0.00811	CbGeAlD
Sulfinpyrazone—ABCB1—bone marrow—hematologic cancer	0.000174	0.00785	CbGeAlD
Sulfinpyrazone—ABCB1—lung—hematologic cancer	0.000158	0.00711	CbGeAlD
Sulfinpyrazone—ABCB1—testis—hematologic cancer	0.000149	0.00671	CbGeAlD
Sulfinpyrazone—ABCB1—lymph node—hematologic cancer	0.000108	0.00486	CbGeAlD
Sulfinpyrazone—Clotrimazole—ABCB1—hematologic cancer	4.42e-05	0.168	CrCbGaD
Sulfinpyrazone—CYP2C8—Metabolism—NUP214—hematologic cancer	4.48e-06	7.49e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—BAD—hematologic cancer	4.46e-06	7.45e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.43e-06	7.41e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—IDH1—hematologic cancer	4.43e-06	7.41e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—STAT3—hematologic cancer	4.42e-06	7.4e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—NRAS—hematologic cancer	4.41e-06	7.38e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—NOTCH1—hematologic cancer	4.41e-06	7.38e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—UGT1A1—hematologic cancer	4.41e-06	7.37e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—MTR—hematologic cancer	4.39e-06	7.34e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ABCG2—hematologic cancer	4.39e-06	7.34e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—TXN—hematologic cancer	4.38e-06	7.33e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ABCC3—hematologic cancer	4.38e-06	7.33e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSTO1—hematologic cancer	4.38e-06	7.33e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CD80—hematologic cancer	4.32e-06	7.23e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.32e-06	7.22e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—KIT—hematologic cancer	4.32e-06	7.22e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ENO2—hematologic cancer	4.3e-06	7.2e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—MTHFR—hematologic cancer	4.3e-06	7.2e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.29e-06	7.17e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CRABP1—hematologic cancer	4.29e-06	7.17e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—SPHK1—hematologic cancer	4.29e-06	7.17e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—CREBBP—hematologic cancer	4.28e-06	7.15e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PTPN11—hematologic cancer	4.24e-06	7.09e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—MAPK3—hematologic cancer	4.23e-06	7.07e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ALOX5—hematologic cancer	4.18e-06	6.99e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.18e-06	6.99e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GSTT1—hematologic cancer	4.17e-06	6.98e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PTEN—hematologic cancer	4.14e-06	6.93e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—UGT1A1—hematologic cancer	4.12e-06	6.89e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—MYC—hematologic cancer	4.11e-06	6.88e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.11e-06	6.87e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CREB1—hematologic cancer	4.11e-06	6.87e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—TGFB1—hematologic cancer	4.1e-06	6.86e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—MTAP—hematologic cancer	4.1e-06	6.86e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CD44—hematologic cancer	4.1e-06	6.85e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—NQO1—hematologic cancer	4.1e-06	6.85e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—AKT1—hematologic cancer	4.08e-06	6.83e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—SDC1—hematologic cancer	4.08e-06	6.82e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—BRAF—hematologic cancer	4.06e-06	6.79e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PIK3CD—hematologic cancer	4.06e-06	6.78e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NUP98—hematologic cancer	4.05e-06	6.77e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—IL6R—hematologic cancer	4.01e-06	6.7e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—SLC22A1—hematologic cancer	4.01e-06	6.7e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CRABP1—hematologic cancer	4.01e-06	6.7e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—ALB—hematologic cancer	4e-06	6.7e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CREBBP—hematologic cancer	4e-06	6.69e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—EP300—hematologic cancer	3.95e-06	6.61e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NCOA3—hematologic cancer	3.93e-06	6.57e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ADCY7—hematologic cancer	3.93e-06	6.57e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ALOX5—hematologic cancer	3.9e-06	6.53e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NUP214—hematologic cancer	3.9e-06	6.53e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.9e-06	6.52e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CYCS—hematologic cancer	3.88e-06	6.48e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	3.85e-06	6.44e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.85e-06	6.43e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PIK3R1—hematologic cancer	3.83e-06	6.41e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ABCG2—hematologic cancer	3.82e-06	6.39e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—MTR—hematologic cancer	3.82e-06	6.39e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MAP2K1—hematologic cancer	3.82e-06	6.39e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—KRAS—hematologic cancer	3.8e-06	6.35e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PIK3CD—hematologic cancer	3.79e-06	6.35e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.79e-06	6.34e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NUP98—hematologic cancer	3.78e-06	6.32e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ENO2—hematologic cancer	3.75e-06	6.27e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.68e-06	6.15e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.67e-06	6.14e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.67e-06	6.14e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—FHL2—hematologic cancer	3.65e-06	6.11e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NUP214—hematologic cancer	3.65e-06	6.1e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GSTT1—hematologic cancer	3.64e-06	6.08e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—FGF2—hematologic cancer	3.63e-06	6.08e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CG—hematologic cancer	3.61e-06	6.05e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.61e-06	6.03e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—AGRN—hematologic cancer	3.58e-06	5.99e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PIK3R1—hematologic cancer	3.58e-06	5.99e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—MTR—hematologic cancer	3.57e-06	5.97e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.57e-06	5.97e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—SDC1—hematologic cancer	3.55e-06	5.94e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PIK3CB—hematologic cancer	3.53e-06	5.91e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.53e-06	5.9e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ENO2—hematologic cancer	3.5e-06	5.86e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—PIK3CA—hematologic cancer	3.49e-06	5.84e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—JAK2—hematologic cancer	3.48e-06	5.82e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—NQO1—hematologic cancer	3.47e-06	5.8e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CD44—hematologic cancer	3.47e-06	5.8e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GSTP1—hematologic cancer	3.42e-06	5.72e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.4e-06	5.69e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MDM2—hematologic cancer	3.4e-06	5.69e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—IDH2—hematologic cancer	3.4e-06	5.68e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—HMMR—hematologic cancer	3.4e-06	5.68e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.4e-06	5.68e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.4e-06	5.68e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—CREBBP—hematologic cancer	3.35e-06	5.61e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.34e-06	5.59e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—SDC1—hematologic cancer	3.32e-06	5.55e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MTOR—hematologic cancer	3.31e-06	5.53e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PIK3CB—hematologic cancer	3.31e-06	5.53e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CD4—hematologic cancer	3.3e-06	5.52e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYCS—hematologic cancer	3.28e-06	5.49e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.26e-06	5.45e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ABCB1—hematologic cancer	3.23e-06	5.41e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—HRAS—hematologic cancer	3.23e-06	5.4e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.19e-06	5.34e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.19e-06	5.33e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CD—hematologic cancer	3.18e-06	5.32e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.17e-06	5.3e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—NCOR1—hematologic cancer	3.14e-06	5.25e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GSTM1—hematologic cancer	3.14e-06	5.25e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—ALB—hematologic cancer	3.14e-06	5.25e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.13e-06	5.24e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ACP5—hematologic cancer	3.11e-06	5.2e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CA9—hematologic cancer	3.11e-06	5.2e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CDKN1B—hematologic cancer	3.1e-06	5.19e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—IL6—hematologic cancer	3.09e-06	5.17e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.07e-06	5.13e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PTEN—hematologic cancer	3.05e-06	5.11e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NQO1—hematologic cancer	3.02e-06	5.05e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CD44—hematologic cancer	3.02e-06	5.05e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3R1—hematologic cancer	3e-06	5.02e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.99e-06	5.01e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.93e-06	4.91e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PIK3CA—hematologic cancer	2.92e-06	4.89e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—IDH1—hematologic cancer	2.92e-06	4.89e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—EP300—hematologic cancer	2.91e-06	4.87e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GSTP1—hematologic cancer	2.89e-06	4.84e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—TXN—hematologic cancer	2.89e-06	4.83e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.89e-06	4.83e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.89e-06	4.83e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CDKN1A—hematologic cancer	2.86e-06	4.79e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYCS—hematologic cancer	2.86e-06	4.78e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PTEN—hematologic cancer	2.86e-06	4.78e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—AKT1—hematologic cancer	2.85e-06	4.77e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.84e-06	4.75e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.83e-06	4.73e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NQO1—hematologic cancer	2.82e-06	4.72e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CD44—hematologic cancer	2.82e-06	4.72e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.8e-06	4.68e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—MTHFR—hematologic cancer	2.78e-06	4.64e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CB—hematologic cancer	2.77e-06	4.63e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.76e-06	4.62e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.74e-06	4.58e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—EP300—hematologic cancer	2.73e-06	4.56e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.72e-06	4.54e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYCS—hematologic cancer	2.67e-06	4.47e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.66e-06	4.45e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.66e-06	4.45e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.65e-06	4.44e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—SRC—hematologic cancer	2.65e-06	4.43e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.64e-06	4.42e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.64e-06	4.42e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.58e-06	4.31e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—STAT3—hematologic cancer	2.56e-06	4.28e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—NRAS—hematologic cancer	2.55e-06	4.26e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GSTP1—hematologic cancer	2.52e-06	4.22e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NUP98—hematologic cancer	2.49e-06	4.17e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MAPK3—hematologic cancer	2.44e-06	4.08e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.42e-06	4.05e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.42e-06	4.05e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NUP214—hematologic cancer	2.4e-06	4.02e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PTEN—hematologic cancer	2.39e-06	4e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.39e-06	4e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—AKT1—hematologic cancer	2.39e-06	3.99e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MYC—hematologic cancer	2.38e-06	3.97e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—TGFB1—hematologic cancer	2.37e-06	3.96e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.36e-06	3.94e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—MTR—hematologic cancer	2.36e-06	3.94e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.35e-06	3.94e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.35e-06	3.93e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.33e-06	3.9e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—NCOR1—hematologic cancer	2.32e-06	3.87e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GSTM1—hematologic cancer	2.32e-06	3.87e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ENO2—hematologic cancer	2.31e-06	3.86e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—EP300—hematologic cancer	2.28e-06	3.82e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.28e-06	3.81e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.24e-06	3.75e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.23e-06	3.73e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—KRAS—hematologic cancer	2.19e-06	3.67e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—SDC1—hematologic cancer	2.19e-06	3.66e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.16e-06	3.62e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.16e-06	3.62e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.16e-06	3.62e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PIK3CA—hematologic cancer	2.15e-06	3.6e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.07e-06	3.46e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.05e-06	3.43e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—MTHFR—hematologic cancer	2.05e-06	3.42e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ALB—hematologic cancer	2.02e-06	3.38e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PIK3CA—hematologic cancer	2.02e-06	3.37e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.97e-06	3.3e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3R1—hematologic cancer	1.94e-06	3.24e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.91e-06	3.2e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—HRAS—hematologic cancer	1.87e-06	3.12e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CD44—hematologic cancer	1.86e-06	3.11e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NQO1—hematologic cancer	1.86e-06	3.11e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.83e-06	3.06e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CB—hematologic cancer	1.79e-06	2.99e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—IL6—hematologic cancer	1.79e-06	2.99e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYCS—hematologic cancer	1.76e-06	2.95e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—AKT1—hematologic cancer	1.76e-06	2.94e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.75e-06	2.93e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.74e-06	2.9e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.72e-06	2.88e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ALB—hematologic cancer	1.71e-06	2.87e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CA—hematologic cancer	1.69e-06	2.82e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.69e-06	2.82e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—AKT1—hematologic cancer	1.65e-06	2.75e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.64e-06	2.74e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.61e-06	2.69e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CREBBP—hematologic cancer	1.59e-06	2.67e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.55e-06	2.6e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PTEN—hematologic cancer	1.54e-06	2.58e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.51e-06	2.53e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.51e-06	2.53e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ALB—hematologic cancer	1.49e-06	2.5e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.49e-06	2.49e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—EP300—hematologic cancer	1.47e-06	2.46e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.47e-06	2.46e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.43e-06	2.39e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.43e-06	2.39e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.43e-06	2.39e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.41e-06	2.36e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ALB—hematologic cancer	1.39e-06	2.33e-05	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—AKT1—hematologic cancer	1.38e-06	2.31e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.33e-06	2.23e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.32e-06	2.2e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PTEN—hematologic cancer	1.31e-06	2.19e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.26e-06	2.11e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—EP300—hematologic cancer	1.25e-06	2.08e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.23e-06	2.06e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PTEN—hematologic cancer	1.14e-06	1.9e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.09e-06	1.82e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—EP300—hematologic cancer	1.09e-06	1.82e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PTEN—hematologic cancer	1.06e-06	1.78e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.06e-06	1.77e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—EP300—hematologic cancer	1.01e-06	1.7e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.82e-07	1.64e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.31e-07	1.56e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	9.22e-07	1.54e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ALB—hematologic cancer	9.19e-07	1.54e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—AKT1—hematologic cancer	8.9e-07	1.49e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.8e-07	1.47e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	8.12e-07	1.36e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CA—hematologic cancer	8.03e-07	1.34e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—AKT1—hematologic cancer	7.53e-07	1.26e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.5e-07	1.26e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PTEN—hematologic cancer	7.02e-07	1.17e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—EP300—hematologic cancer	6.69e-07	1.12e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—AKT1—hematologic cancer	6.56e-07	1.1e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—AKT1—hematologic cancer	6.13e-07	1.03e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.95e-07	8.28e-06	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—AKT1—hematologic cancer	4.04e-07	6.76e-06	CbGpPWpGaD
